2m 2m 2m 2m 2m 2m 2m
DIANTHUS (DNTH)
NASDAQ
$86.93-$0.44 (-0.50%)
Price as of Jun 23, 2026 3:15 PM EDT- $4.8BMarket Cap
- 407.97%1-Year Change
- BiotechnologyIndustry
DIANTHUS (DNTH)
$86.93-$0.44 (-0.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 6.2M +10.82% | 5.6M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 6.2M +10.82% | 5.6M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -145.6M +75.25% | -83.1M +153.05% | -32.8M -40.44% | -55.1M +17.91% | |
Depreciation and Amortization Expense | 111,000 +15.63% | 96,000 +43.28% | 67,000 -96.52% | 1.9M -4.70% | |
Total Operating Expenses | 180.0M +66.49% | 108.1M +111.96% | 51.0M -36.96% | 80.9M +8.31% | |
Operating Profit | -177.9M +74.68% | -101.9M +111.45% | -48.2M -40.45% | -80.9M +8.31% | |
Interest Income | 16.1M -7.18% | 17.4M +264.50% | 4.8M +7.30% | 4.4M +24.86% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 16.1M -7.18% | 17.4M +264.50% | 4.8M +7.30% | 4.4M +24.86% | |
Total Nonoperating Income and Expense | 15.6M -7.69% | 16.9M +265.77% | 4.6M N/A | N/A N/A | |
Income before Taxes | -177.9M +74.68% | -101.9M +111.45% | -48.2M -40.45% | -80.9M +8.31% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -162.3M +91.05% | -85.0M +95.08% | -43.6M -43.04% | -76.5M +7.49% | |
Net Income from Continuing Operations Applicable to Common | -162.3M +91.05% | -85.0M +95.08% | -43.6M -43.04% | -76.5M +7.49% | |
Basic EPS and Net Income | -4.20 +64.71% | -2.55 -69.82% | -8.45 +555.04% | -1.29 0.00% | |
Diluted EPS and Net Income | -4.20 +64.71% | -2.55 -69.82% | -8.45 +555.04% | -1.29 0.00% | |
Basic Weighted Average Shares | 38.6M +15.92% | 33.3M +546.44% | 5.2M -91.32% | 59.4M +8.05% | |
Diluted Weighted Average Shares | 38.6M +15.92% | 33.3M +546.44% | 5.2M -91.32% | 59.4M +8.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 51.1M +124.14% | 22.8M -82.78% | 132.3M +129.63% | 57.6M -56.23% | |
Short-Term Investments | 353.2M +39.91% | 252.4M +509.88% | 41.4M -23.93% | 54.4M +20.19% | |
Cash and Cash Equivalents and Short-Term Investments | 404.3M +46.89% | 275.2M +58.44% | 173.7M +55.05% | 112.0M -36.67% | |
Total Current Assets | 409.4M +45.76% | 280.9M +58.30% | 177.5M +53.50% | 115.6M -36.02% | |
Accumulated Depreciation | 304,000 +57.51% | 193,000 +98.97% | 97,000 -98.87% | 8.6M +28.84% | |
Property and Plant and Equipment and Net | 296,000 +52.58% | 194,000 +4.86% | 185,000 -96.96% | 6.1M -18.31% | |
Total Long-Term Assets | 296,000 +52.58% | 194,000 +4.86% | 185,000 -96.96% | 6.1M -18.31% | |
Total Assets | 530.9M +41.95% | 374.0M +108.47% | 179.4M +22.34% | 146.6M -22.79% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 100,000 -50.00% | |
Total Current Liabilities | 30.7M +66.55% | 18.5M +91.59% | 9.6M -33.80% | 14.5M +33.93% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 6.8M +120.49% | 3.1M +240.60% | 904,000 -96.54% | 26.1M +308.47% | |
Total Liabilities | 37.5M +74.27% | 21.5M +104.38% | 10.5M -74.11% | 40.7M +135.70% | |
Retained Earnings | -336.7M +93.09% | -174.4M +95.02% | -89.4M -77.76% | -402.0M +23.49% | |
Total Stockholders Equity | 493.4M +39.98% | 352.5M +108.73% | 168.9M +59.37% | 106.0M -38.64% | |
Total Shares Outstanding | 43.2M +38.91% | 31.1M +109.99% | 14.8M -75.56% | 60.6M +3.13% | |
Cash Flow | |||||
Cash from Operating Activities | -129.1M +65.08% | -78.2M +112.09% | -36.9M -45.06% | -67.1M +12.70% | |
Capital Expenditures | 213,000 +102.86% | 105,000 -4.55% | 110,000 -64.97% | 314,000 -75.16% | |
Cash from Investing Activities | -122.8M -57.17% | -286.8M -1,516.15% | 20.3M +306.41% | -9.8M -122.59% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 280.1M +9.59% | 255.6M +91.37% | 133.6M +4,541.21% | 2.9M -96.79% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -1,633.74% +90.80% | -856.27% N/A | N/A N/A | |
Return on Assets | -35.88% +16.84% | -30.71% +14.94% | -26.72% -41.20% | -45.43% +12.27% | |
Return on Equity | -38.38% +17.75% | -32.60% +2.84% | -31.70% -42.25% | -54.88% +22.13% | |
Revenue Growth | -100.00% -1,023.81% | 10.82% N/A | N/A N/A | N/A N/A | |
Current Ratio | 13.32 -12.48% | 15.22 -17.38% | 18.43 +131.89% | 7.95 -52.23% | |
Cash Ratio | 1.66 +34.58% | 1.24 -91.01% | 13.74 +246.89% | 3.96 -67.32% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow